VCEL
Vericel Corp
Key Financials
Net Income
$16.5M
↑ 59.4%
Revenue
$276.3M
↑ 16.5%
Shareholders' Equity
$354.6M
↑ 21.5%
EPS (Diluted)
$0.32
↑ 60.0%
Cash & Equivalents
$100.1M
↑ 34.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
| 144 | 8/12/2026 | View on SEC |
| 4 | 8/5/2026 | View on SEC |
| 144 | 8/3/2026 | View on SEC |
| 4 | 7/31/2026 | View on SEC |
| 144 | 7/30/2026 | View on SEC |
| 10-Q | 7/30/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VCEL |
| Company Name | Vericel Corp |
| CIK | 887359 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | MI |
| Phone | 6175885555 |